Zhong Huang Selected Research

Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease)

1/2019	Coxsackievirus A10 atomic structure facilitating the discovery of a broad-spectrum inhibitor against human enteroviruses.
5/2018	A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity.
1/2018	A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection.
1/2018	Structure, Immunogenicity, and Protective Mechanism of an Engineered Enterovirus 71-Like Particle Vaccine Mimicking 80S Empty Capsid.
1/2018	A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
1/2017	Interleukin-18 protects mice from Enterovirus 71 infection.
1/2016	Inactivated coxsackievirus A10 experimental vaccines protect mice against lethal viral challenge.
9/2015	Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71.
2/2015	Towards broadly protective polyvalent vaccines against hand, foot and mouth disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhong Huang Research Topics

Disease

41	Infections 01/2021 - 03/2006
12	Neoplasms (Cancer) 06/2022 - 03/2009
12	Inflammation (Inflammations) 07/2021 - 06/2007
9	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 01/2019 - 02/2015
7	Virus Diseases (Viral Diseases) 01/2021 - 01/2013
4	COVID-19 12/2021 - 05/2021
4	Coinfection 05/2018 - 05/2010
4	Rheumatoid Arthritis 05/2017 - 03/2013
3	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2018
3	Fistula 03/2022 - 01/2020
3	Hypoxia (Hypoxemia) 01/2022 - 01/2015
3	Myocardial Infarction 06/2021 - 04/2017
3	Pain (Aches) 03/2021 - 01/2009
3	Zika Virus Infection 01/2021 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 06/2015
3	Experimental Arthritis 01/2018 - 04/2014
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 07/2021
2	Human Influenza (Influenza) 01/2021 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 06/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 03/2014
2	Disease Resistance 03/2018 - 03/2015
2	Arthritis (Polyarthritis) 01/2018 - 04/2014
2	Body Weight (Weight, Body) 11/2017 - 07/2017
2	Weight Gain 11/2017 - 07/2017
2	Wound Infection (Wound Infections) 09/2017 - 01/2017
1	Type I Syndactyly 12/2022
1	Melena 03/2022
1	Hematemesis 03/2022
1	Foreign Bodies (Foreign Body) 03/2022
1	Colitis 01/2022
1	Clostridium Infections 01/2022
1	Ulcer 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Chronic Renal Insufficiency 11/2021

Drug/Important Bio-Agent (IBA)

28	VaccinesIBA 01/2021 - 04/2006
11	Proteins (Proteins, Gene)FDA Link 06/2022 - 01/2006
11	CytokinesIBA 01/2022 - 06/2007
7	AntibodiesIBA 01/2022 - 01/2013
7	Neutralizing AntibodiesIBA 12/2021 - 01/2013
5	Broadly Neutralizing AntibodiesIBA 08/2021 - 03/2016
5	Antiviral Agents (Antivirals)IBA 05/2021 - 03/2014
5	Messenger RNA (mRNA)IBA 10/2020 - 05/2007
5	Combined VaccinesIBA 05/2018 - 05/2014
5	Immune Sera (Antisera)IBA 01/2018 - 01/2013
4	Pharmaceutical PreparationsIBA 11/2021 - 01/2019
4	MicroRNAs (MicroRNA)IBA 01/2021 - 03/2018
4	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2014
3	Long Noncoding RNAIBA 06/2022 - 12/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2017
3	AntigensIBA 01/2022 - 03/2013
3	Biological ProductsIBA 01/2021 - 01/2006
3	antineoplaston A10 (A 10)IBA 01/2019 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 12/2018 - 04/2014
3	AntioxidantsIBA 03/2018 - 01/2013
3	Inactivated VaccinesIBA 01/2018 - 04/2013
2	Immune Checkpoint InhibitorsIBA 06/2022 - 01/2019
2	Protein Subunit VaccinesIBA 08/2021 - 01/2018
2	Collagen Type II (Type II Collagen)IBA 07/2021 - 04/2014
2	CollagenIBA 07/2021 - 01/2018
2	Therapeutic UsesIBA 06/2021 - 01/2020
2	Mitogen-Activated Protein KinasesIBA 10/2020 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 06/2019
2	Monoclonal AntibodiesIBA 12/2019 - 05/2014
2	Protein Subunits (Protein Subunit)IBA 10/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2019
2	EnzymesIBA 07/2017 - 01/2014
2	Interleukin-18 (Interleukin 18)IBA 01/2017 - 06/2007
2	InflammasomesIBA 01/2017 - 07/2015
2	Interleukin-1 (Interleukin 1)IBA 06/2015 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 08/2007
1	EpitopesIBA 12/2022
1	allogenic effect factor (AEF)IBA 03/2022
1	ProdrugsIBA 01/2022
1	Tirapazamine (SR 4233)IBA 01/2022
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	Dextran SulfateIBA 01/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022
1	PorphyrinsIBA 01/2022
1	Radioisotopes (Radionuclides)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Metal-Organic FrameworksIBA 01/2022
1	PolyvinylsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	Pyrrolidinones (Pyrrolidones)IBA 01/2022
1	tetracarboxyphenylporphineIBA 01/2022
1	iron 5,10,15,20- tetrakis- 4- carboxyphenylporphyrinIBA 01/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021

Therapy/Procedure

10	Therapeutics 06/2022 - 07/2008
4	Drug Therapy (Chemotherapy) 01/2022 - 06/2019
2	Fecal Microbiota Transplantation 01/2022 - 01/2022
2	Length of Stay 03/2021 - 12/2019
2	Hip Replacement Arthroplasty (Total Hip Replacement) 03/2021 - 12/2019
2	Intraperitoneal Injections 01/2018 - 05/2007
2	Debridement 09/2017 - 01/2017
1	Oncolytic Virotherapy 06/2022
1	Stents 03/2022
1	Gastroscopes 01/2022
1	Photochemotherapy (Photodynamic Therapy) 01/2022